Hallmarks of Cellular Senescence

Trends in Cell Biology

Volumn 28, Issue 6, 2018, Pages 436-453

  Hernandez Segura, Alejandra ^a   Nehme, Jamil ^a   Demaria, Marco ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA; INFLAMMASOME; REACTIVE OXYGEN METABOLITE; BIOLOGICAL MARKER;

APOPTOSIS; BIOACCUMULATION; CELL AGING; CELL CYCLE ARREST; CELL MEMBRANE; CELL METABOLISM; CELL NUCLEUS; CELL SHAPE; CELL SIZE; DNA DAMAGE RESPONSE; ENDOPLASMIC RETICULUM STRESS; HETEROCHROMATIN; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; LYSOSOME; MEMBRANE BIOLOGY; MITOCHONDRION; MOLECULAR DYNAMICS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SECRETORY PATHWAY; AGING; DNA DAMAGE; GENETIC MARKER; GENETICS; HUMAN; METABOLISM;

AGING; BIOMARKERS; CELLULAR SENESCENCE; DNA DAMAGE; GENETIC MARKERS; HUMANS; PHENOTYPE;

EID: 85042223621     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2018.02.001     Document Type: Review

References (163)

1. López-Otín, C., et al. The hallmarks of aging. Cell 153 (2013), 1194–1217.
2. Muñoz-Espín, D., Serrano, M., Cellular senescence: from physiology to pathology. Nat. Rev. Mol. Cell Biol. 15 (2014), 482–496.
3. Sharpless, N.E., Sherr, C.J., Forging a signature of in vivo senescence. Nat. Rev. Cancer 15 (2015), 397–408.
4. Lecot, P., et al. Context-dependent effects of cellular senescence in cancer development. Br. J. Cancer 114 (2016), 1180–1184.
5. Adams, P.D., Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol. Cell 36 (2009), 2–14.
6. Demaria, M., et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 31 (2014), 722–733.
7. Soto-Gamez, A., Demaria, M., Therapeutic interventions for aging: the case of cellular senescence. Drug Discov. Today 22 (2017), 786–795.
8. Shiloh, Y., The ATM-mediated DNA-damage response: taking shape. Trends Biochem. Sci. 31 (2006), 402–410.
9. Zou, L., Single- and double-stranded DNA: Building a trigger of ATR-mediated DNA damage response. Genes Dev. 21 (2007), 879–885.
10. Celeste, A., et al. Genomic instability in mice lacking histone H2AX. Science 296 (2002), 922–927.
11. Ayrapetov, M.K., et al. DNA double-strand breaks promote methylation of histone H3 on lysine 9 and transient formation of repressive chromatin. Proc. Natl. Acad. Sci. 111 (2014), 9169–9174.
12. Takahashi, A., et al. DNA damage signaling triggers degradation of histone methyltransferases through APC/C Cdh1 in senescent cells. Mol. Cell 45 (2012), 123–131.
13. Bekker-Jensen, S., et al. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J. Cell Biol. 173 (2006), 195–206.
14. Lukas, C., et al. Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nat. Cell Biol. 5 (2003), 255–260.
15. Turenne, G.A., et al. Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53. Oncogene 20 (2001), 5100–5110.
16. Burd, C.E., et al. Monitoring tumorigenesis and senescence in vivo with a p16INK4a –luciferase model. Cell 152 (2013), 340–351.
17. Baker, D.J., et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479 (2011), 232–236.
18. Velicescu, M., et al. Cell division is required for de novo methylation of CpG islands in bladder cancer cells. Cancer Res. 62 (2002), 2378–2384.
19. Venturelli, S., et al. Differential induction of apoptosis and senescence by the DNA methyltransferase inhibitors 5-azacytidine and 5-aza-2′-deoxycytidine in solid tumor cells. Mol. Cancer Ther. 12 (2013), 2226–2236.
20. Zhu, B., et al. Atorvastatin treatment modulates p16 promoter methylation to regulate p16 expression. FEBS J. 284 (2017), 1868–1881.
21. Pan, K., et al. HBP1-mediated transcriptional regulation of DNA methyltransferase 1 and its impact on cell senescence. Mol. Cell Biol. 33 (2013), 887–903.
22. Nehls, K., et al. P16 methylation does not affect protein expression in cervical carcinogenesis. Eur. J. Cancer 44 (2008), 2496–2505.
23. Li, J., et al. Regulatory mechanisms of tumor suppressor P16 INK4A and their relevance to cancer. Biochemistry 50 (2011), 5566–5582.
24. Yap, K.L., et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell 38 (2010), 662–674.
25. Barzily-Rokni, M., et al. Synergism between DNA methylation and macroH2A1 occupancy in epigenetic silencing of the tumor suppressor gene p16(CDKN2A). Nucleic Acids Res. 39 (2011), 1326–1335.
26. Wang, X., et al. The proximal GC-rich region of p16INK4a gene promoter plays a role in its transcriptional regulation. Mol. Cell. Biochem. 301 (2007), 259–266.
27. Ohtani, N., et al. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409 (2001), 1067–1070.
28. Passegue, E., JunB suppresses cell proliferation by transcriptional activation of p16INK4a expression. EMBO J. 19 (2000), 2969–2979.
29. Gan, Q., et al. PPAR accelerates cellular senescence by inducing p16INK4 expression in human diploid fibroblasts. J. Cell Sci. 121 (2008), 2235–2245.
30. Huang, Y., et al. B-MYB delays cell aging by repressing p16 INK4α transcription. Cell. Mol. Life Sci. 68 (2011), 893–901.
31. Kotake, Y., et al. YB1 binds to and represses the p16 tumor suppressor gene. Genes Cells 18 (2013), 999–1006.
32. Zhu, D., et al. Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins: Implications for cellular senescence. J. Cell. Physiol. 193 (2002), 19–25.
33. Guo, G.E., et al. Hydrogen peroxide induces p16INK4a through an AUF1-dependent manner. J. Cell. Biochem. 109 (2010), 1000–1005.
34. Al-Khalaf, H.H., Aboussekhra, A., P16INK4A positively regulates p21WAF1 expression by suppressing AUF1-dependent mRNA decay. PLoS One 8 (2013), 13–15.
35. Bisio, A., et al. The 5′-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding. Oncotarget 6 (2015), 39980–39994.
36. Lu, Y., et al. The interplay between p16 serine phosphorylation and arginine methylation determines its function in modulating cellular apoptosis and senescence. Sci. Rep., 7, 2017, 41390.
37. Ben-Saadon, R., et al. The tumor suppressor protein p16INK4a and the human papillomavirus oncoprotein-58 E7 are naturally occurring lysine-less proteins that are degraded by the ubiquitin system: Direct evidence for ubiquitination at the N-terminal residue. J. Biol. Chem. 279 (2004), 41414–41421.
38. Ko, A., et al. Dynamics of ARF regulation that control senescence and cancer. BMB Rep. 49 (2016), 598–606.
39. Carr, M.I., Jones, S.N., Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis, 5, 2016, 707–724.
40. Marthandan, S., et al. Conserved senescence associated genes and pathways in primary human fibroblasts detected by RNA-seq. PLoS One, 11, 2016, e0154531.
41. Malumbres, M., et al. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b). Mol. Cell. Biol. 20 (2000), 2915–2925.
42. INK4b signaling. Cell. Mol. Life Sci. 72 (2015), 2949–2960.
43. Huang, W., et al. Histone deacetylase 3 represses p15INK4b and p21 WAF1/cip1 transcription by interacting with Sp1. Biochem. Biophys. Res. Commun. 339 (2006), 165–171.
44. Culerrier, R., et al. MSK1 triggers the expression of the INK4AB/ARF locus in oncogene-induced senescence. Mol. Biol. Cell 27 (2016), 2726–2734.
45. Aesoy, R., et al. Regulation of CDKN2B expression by interaction of Arnt with Miz-1 – a basis for functional integration between the HIF and Myc gene regulatory pathways. Mol. Cancer, 13, 2014, 54.
46. Schwaller, J., et al. Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells. Leukemia 11 (1997), 54–63.
47. Sandhu, C., et al. Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol. Cell. Biol. 17 (1997), 2458–2467.
48. Jung, Y.-S., et al. Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal. 22 (2010), 62–70.
49. Hernandez-Segura, A., et al. Unmasking transcriptional heterogeneity in senescent cells. Curr. Biol. 27 (2017), 2652–2660.
50. Koo, B.-H., et al. Distinct roles of transforming growth factor-β signaling and transforming growth factor-β receptor inhibitor SB431542 in the regulation of p21 expression. Eur. J. Pharmacol. 764 (2015), 413–423.
51. Coppé J.-P., et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6 (2008), 2853–2868.
52. Coppé J.-P., et al. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5 (2010), 99–118.
53. Ohanna, M., et al. Senescent cells develop a PARP-1 and nuclear factor- k B-associated secretome (PNAS). Genes Dev. 25 (2011), 1245–1261.
54. Yang, H., et al. cGAS is essential for cellular senescence. Proc. Natl. Acad. Sci. 114 (2017), E4612–E4620.
55. Dou, Z., et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature 550 (2017), 402–406.
56. Wiley, C.D., et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 23 (2016), 303–314.
57. Kuilman, T., et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133 (2008), 1019–1031.
58. Kang, C., et al. The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science, 349, 2015, aaa5612.
59. Hoare, M., et al. NOTCH1 mediates a switch between two distinct secretomes during senescence. Nat. Cell Biol. 18 (2016), 979–992.
60. Toso, A., et al. Enhancing chemotherapy efficacy in pten-deficient prostate tumors by activating the senescence-associated antitumor immunity. Cell Rep. 9 (2014), 75–89.
61. Hayakawa, T., et al. SIRT1 suppresses the senescence-associated secretory phenotype through epigenetic gene regulation. PLoS One 10 (2015), 1–16.
62. Chen, H., et al. MacroH2A1 and ATM play opposing roles in paracrine senescence and the senescence-associated secretory phenotype. Mol. Cell 59 (2015), 719–731.
63. Contrepois, K., et al. Histone variant H2A.J. accumulates in senescent cells and promotes inflammatory gene expression. Nat. Commun., 8, 2017, 14995.
64. Tasdemir, N., et al. BRD4 connects enhancer remodeling to senescence immune surveillance. Cancer Discov. 6 (2016), 613–629.
65. Aird, K.M., et al. HMGB2 orchestrates the chromatin landscape of senescence-associated secretory phenotype gene loci. J. Cell Biol. 215 (2016), 325–334.
66. Laberge, R.-M., et al. mTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat. Cell Biol. 17 (2015), 1049–1061.
67. Herranz, N., et al. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat. Cell Biol. 17 (2015), 1205–1217.
68. Bent, E.H., et al. A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses. Genes Dev. 30 (2016), 1811–1821.
69. Tiedje, C., et al. The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation. PLoS Genet., 8, 2012, e1002977.
70. Acosta, J.C., et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15 (2013), 978–990.
71. Acosta, J.C., et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133 (2008), 1006–1018.
72. Coppe, J.P., et al. A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS One, 5, 2010, e9188.
73. Stow, J.L., Murray, R.Z., Intracellular trafficking and secretion of inflammatory cytokines. Cytokine Growth Factor Rev. 24 (2013), 227–239.
74. Effenberger, T., et al. Senescence-associated release of transmembrane proteins involves proteolytic processing by ADAM17 and microvesicle shedding. FASEB J. 28 (2014), 4847–4856.
75. Morancho, B., et al. Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence. Breast Cancer Res., 17, 2015, 106.
76. Takasugi, M., et al. Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2. Nat. Commun. 8 (2017), 1–11.
77. Lehmann, B.D., et al. Senescence-associated exosome release from human prostate cancer cells. Cancer Res. 68 (2008), 7864–7871.
78. Jun, J. II, Lau, L.F., Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat. Rev. Drug Discov. 10 (2011), 945–963.
79. Demaria, M., et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 7 (2017), 165–176.
80. Baker, D.J., et al. Naturally occurring p16 Ink4a - positive cells shorten healthy lifespan. Nature 530 (2016), 184–189.
81. Childs, B.G., et al. Senescence and apoptosis: dueling or complementary cell fates?. EMBO Rep. 15 (2014), 1139–1153.
82. Ryu, S.J., et al. Failure of stress-induced downregulation of Bcl-2 contributes to apoptosis resistance in senescent human diploid fibroblasts. Cell Death Differ. 14 (2007), 1020–1028.
83. Sanders, Y.Y., et al. Histone modifications in senescence-associated resistance to apoptosis by oxidative stress. Redox Biol. 1 (2013), 8–16.
84. Zhu, Y., et al. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging 14 (2015), 644–658.
85. Yosef, R., et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat. Commun., 7, 2016, 11190.
86. Baar, M.P., et al. Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell 169 (2017), 132–147.
87. Yosef, R., et al. p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling. EMBO J. 36 (2017), 2280–2295.
88. Fuhrmann-Stroissnigg, H., et al. Identification of HSP90 inhibitors as a novel class of senolytics. Nat. Commun., 8, 2017, 422.
89. Boise, L.H., et al. Bcl-X, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74 (1993), 597–608.
90. James, E.L., et al. Senescent human fibroblasts show increased glycolysis and redox homeostasis with extracellular metabolomes that overlap with those of irreparable DNA damage, aging, and disease. J. Proteome Res. 14 (2015), 1854–1871.
91. Xiao, B., et al. Structure of mammalian AMPK and its regulation by ADP. Nature 472 (2011), 230–233.
92. Strycharz, J., et al. Is p53 involved in tissue-specific insulin resistance formation?. Oxid. Med. Cell. Longev., 2017, 2017, 9270549.
93. Kaplon, J., et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 498 (2013), 109–112.
94. Yin, Y., Shen, W.H., PTEN: a new guardian of the genome. Oncogene 27 (2008), 5443–5453.
95. Correia-Melo, C., Passos, J.F., Mitochondria: are they causal players in cellular senescence?. Biochim. Biophys. Acta 1847 (2015), 1373–1379.
96. Correia-Melo, C., et al. Mitochondria are required for pro-ageing features of the senescent phenotype. EMBO J. 35 (2016), 724–742.
97. Nacarelli, T., Sell, C., Targeting metabolism in cellular senescence, a role for intervention. Mol. Cell. Endocrinol. 455 (2016), 83–92.
98. Gewirtz, D.A., Autophagy and senescence. Autophagy, 9, 2013, 808812.
99. Takebayashi, S., et al. Retinoblastoma protein promotes oxidative phosphorylation through upregulation of glycolytic genes in oncogene-induced senescent cells. Aging Cell 14 (2015), 689–697.
100. Nicolay, B.N., Dyson, N.J., The multiple connections between pRB and cell metabolism. Curr. Opin. Cell Biol. 25 (2013), 735–740.
101. Wiley, C.D., Campisi, J., Review from ancient pathways to aging cells — connecting metabolism and cellular senescence. Cell Metab. 23 (2016), 1013–1021.
102. Aird, K.M., Zhang, R., Metabolic alterations accompanying oncogene-induced senescence. Mol. Cell. Oncol., 1, 2014, e963481.
103. Wu, M., et al. Metabolomics-proteomics combined approach identifies differential metabolism-associated molecular events between senescence and apoptosis. J. Proteome Res. 16 (2017), 2250–2261.
104. Kim, J.S., et al. Proteomic and metabolomic analysis of H2O2-induced premature senescent human mesenchymal stem cells. Exp. Gerontol. 46 (2011), 500–510.
105. Pluquet, O., et al. The unfolded protein response and cellular senescence. A review in the theme: cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. Am. J. Physiol. Cell Physiol. 308 (2015), C415–C425.
106. Druelle, C., et al. ATF6a regulates morphological changes associated with senescence in human fibroblasts. Oncotarget 7 (2016), 67699–67715.
107. Cormenier, J., et al. The ATF6α arm of the Unfolded Protein Response mediates replicative senescence in human fibroblasts through a COX2/prostaglandin E 2 intracrine pathway. Mech. Ageing Dev., 2017, 10.1016/j.mad.2017.08.003 Published online August 10, 2017.
108. Liu, Y., et al. Endoplasmic reticulum stress participates in the progress of senescence and apoptosis of osteoarthritis chondrocytes. Biochem. Biophys. Res. Commun. 491 (2017), 368–373.
109. Matos, L., et al. ER Stress response in human cellular models of senescence. J. Gerontol. A Biol. Sci. Med. Sci. 70 (2014), 924–935.
110. Wang, M., Kaufman, R.J., The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat. Rev. Cancer 14 (2014), 581–597.
111. Gülow, K., et al. BiP is feed-back regulated by control of protein translation efficiency. J. Cell Sci. 115 (2002), 2443–2452.
112. Lloyd, A.C., The regulation of cell size. Cell 154 (2013), 1194–1205.
113. Blagosklonny, M.V., Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR – driven aging. Aging (Albany. NY) 4 (2012), 159–165.
114. Loffredo, F.S., et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 153 (2013), 828–839.
115. Avruch, J., et al. Activation of mTORC1 in two steps: Rheb-GTP activation of catalytic function and increased binding of substrates to raptor. Biochem. Soc. Trans. 37 (2009), 223–226.
116. Hwang, E.S., et al. A comparative analysis of the cell biology of senescence and aging. Cell. Mol. Life Sci. 66 (2009), 2503–2524.
117. Tam, A.B., et al. ER stress activates NF-kB by integrating functions of basal IKK activity, IRE1 and PERK. PLoS One, 7, 2012, e45078.
118. Rao, J., et al. ATF6 mediates a pro-inflammatory synergy between ER stress and TLR activation in the pathogenesis of liver ischemia reperfusion injury. Am. J. Transplant. 14 (2014), 1552–1561.
119. Ohno-Iwashita, Y., et al. Plasma membrane microdomains in aging and disease. Geriatr. Gerontol. Int. 10:Suppl. 1 (2010), S41–S52.
120. van Deursen, J.M., The role of senescent cells in ageing. Nature 509 (2014), 439–446.
121. Dasari, A., et al. Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements. Cancer Res. 66 (2006), 10805–10814.
122. Chrétien, A., et al. Increased abundance of cytoplasmic and nuclear caveolin 1 in human diploid fibroblasts in H2O2-induced premature senescence and interplay with p38αMAPK. FEBS Lett. 582 (2008), 1685–1692.
123. Cho, K.A., et al. Morphological adjustment of senescent cells by modulating caveolin-1 status. J. Biol. Chem. 279 (2004), 42270–42278.
124. Inomata, M., et al. Detachment-associated changes in lipid rafts of senescent human fibroblasts. Biochem. Biophys. Res. Commun. 343 (2006), 489–495.
125. Volonte, D., et al. Oxidative stress-induced inhibition of Sirt1 by caveolin-1 promotes p53-dependent premature senescence and stimulates the secretion of interleukin 6 (IL-6). J. Biol. Chem. 290 (2015), 4202–4214.
126. Zou, H., et al. Caveolin-1, cellular senescence and age-related diseases. Mech. Ageing Dev. 132 (2011), 533–542.
127. Althubiti, M., et al. Characterization of novel markers of senescence and their prognostic potential in cancer. Cell Death Dis., 5, 2014, e1528.
128. Frescas, D., et al. Senescent cells expose and secrete an oxidized form of membrane-bound vimentin as revealed by a natural polyreactive antibody. Proc. Natl. Acad. Sci. 114 (2017), E1668–E1677.
129. Kim, K.M., et al. Identification of senescent cell surface targetable protein DPP4. Genes Dev. 31 (2017), 1529–1534.
130. Cho, S., Hwang, E.S., Status of mTOR activity may phenotypically differentiate senescence and quiescence. Mol. Cells 33 (2012), 597–604.
131. Lee, B.Y., et al. Senescence-associated β-galactosidase is lysosomal β-galactosidase. Aging Cell 5 (2006), 187–195.
132. Kurz, D.J., et al. Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J. Cell Sci. 113 (2000), 3613–3622.
133. Morreau, H., et al. Alternative splicing of beta-galactosidase mRNA generates the classic lysosomal enzyme and a beta-galactosidase-related protein. J. Biol. Chem. 264 (1989), 20655–20663.
134. Morreau, H., et al. Organization of the gene encoding human lysosomal ß-galactosidase. DNA Cell Biol. 10 (1991), 495–504.
135. Santamaria, R., et al. SR proteins and the nonsense-mediated decay mechanism are involved in human GLB1 gene alternative splicing. BMC Res. Notes, 1, 2008, 137.
136. van der Spoel, A., et al. Processing of lysosomal beta-galactosidase. J. Biol. Chem. 275 (2000), 10035–10040.
137. Georgakopoulou, E.A., et al. Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues. Aging (Albany (NY) 5 (2013), 37–50.
138. Urbanelli, L., et al. Oncogenic H-Ras up-regulates acid β-hexosaminidase by a mechanism dependent on the autophagy regulator TFEB. PLoS One, 9, 2014, e89485.
139. Gianfranceschi, G., et al. Critical role of lysosomes in the dysfunction of human cardiac stem cells obtained from failing hearts. Int. J. Cardiol. 216 (2016), 140–150.
140. Evangelou, K., et al. Robust, universal biomarker assay to detect senescent cells in biological specimens. Aging Cell 16 (2017), 192–197.
141. Kopp, H.G., et al. β-galactosidase staining on bone marrow. The osteoclast pitfall. Histol. Histopathol. 22 (2007), 971–976.
142. Tai, H., et al. Autophagy impairment with lysosomal and mitochondrial dysfunction is an important characteristic of oxidative stress-induced senescence. Autophagy 13 (2017), 99–113.
143. Passos, J.F., et al. Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol. 5 (2007), 1138–1151.
144. Studencka, M., Schaber, J., Senoptosis: non-lethal DNA cleavage as a route to deep senescence. Oncotarget 8 (2017), 30656–30671.
145. Korolchuk, V.I., et al. Mitochondria in cell senescence: Is mitophagy the weakest link?. EBioMedicine 21 (2017), 7–13.
146. Dalle Pezze, P., et al. Dynamic modelling of pathways to cellular senescence reveals strategies for targeted interventions. PLoS Comput. Biol., 10, 2014, e1003728.
147. Chen, Y., Dorn, G.W. II, PINK1-phosphorylated mitofusin 2 is a parkin receptor for culling damaged mitochondria. Science 340 (2013), 471–475.
148. Hoshino, A., et al. Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart. Nat. Commun. 4 (2013), 1–12.
149. García-Prat, L., et al. Autophagy maintains stemness by preventing senescence. Nature 529 (2016), 37–42.
150. Cunningham, J.T., et al. mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex. Nature 450 (2007), 736–740.
151. Sadaie, M., et al. Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence. Genes Dev. 27 (2013), 1800–1808.
152. Ivanov, A., et al. Lysosome-mediated processing of chromatin in senescence. J. Cell Biol. 202 (2013), 129–143.
153. Chandra, T., et al. Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation. Mol. Cell 47 (2012), 203–214.
154. Chandra, T., Kirschner, K., Chromosome organisation during ageing and senescence. Curr. Opin. Cell Biol. 40 (2016), 161–167.
155. Dreesen, O., et al. Lamin B1 fluctuations have differential effects on cellular proliferation and senescence. J. Cell Biol. 200 (2013), 605–617.
156. Dou, Z., et al. Autophagy mediates degradation of nuclear lamina. Nature 527 (2015), 105–109.
157. Freund, A., et al. Lamin B1 loss is a senescence-associated biomarker. Mol. Biol. Cell 23 (2012), 2066–2075.
158. Milanovic, M., et al. Senescence-associated reprogramming promotes cancer stemness. Nature 553 (2017), 96–100.
159. Xie, J., et al. mTOR inhibitors in cancer therapy. F1000Res., 5, 2016, 2078.
160. Hayflick, L., Moorhead, P.S., The serial cultivation of human diploid cell strains. Exp. Cell Res. 25 (1961), 585–621.
161. Pfaffl, M.W., Relative quantification. Dorak, T., (eds.) Real Time PCR, 2006, International University, 63–82.
162. Wiley, C.D., et al. Analysis of individual cells identifies cell-to-cell variability following induction of cellular senescence. Aging Cell 16 (2017), 1043–1050.
163. Petrova, N.V., et al. Small molecule compounds that induce cellular senescence. Aging Cell 15 (2016), 999–1017.